Recent scientific developments, particularly in antibody engineering, have led to numerous innovations in cancer immunotherapy and one of the most promising innovations has been the development of bispecific antibodies, as bispecific drugs make huge waves in multiple myeloma and lymphoma, so much so that they threaten cell therapy in multiple myeloma.
The 2025 NIH Spring Research Vendor Fair is a premier event that brings together leading researchers, innovative contract research organizations, and cutting-edge technology providers in the biomedical research ecosystem. This comprehensive marketplace offers an unparalleled opportunity for professionals to explore the latest advancements in clinical research, discover breakthrough technologies, and network with industry experts from across the United States.
In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements to enable presymptomatic diagnosis, reinvigorating the space with new targets, modalities, and technologies. Meanwhile significant advancements to target the likes of α-synuclein, NLRP3 and GBA suggest only a matter of time until a disease-modifying therapy emerges on the scene for Parkinson’s too.
At Johns Hopkins, experts across various disciplines have come together to achieve a new level of precision in health care. Combining the knowledge of specialists from one of the world’s pre-eminent academic medical centers, renowned public health scholars and some of the best systems engineers on planet - Johns Hopkins in Health is continuing to explore and develop precision medicine approaches that will lead to quicker diagnoses, improved treatment and better outcomes. Johns Hopkins School of Medicine was awarded $335M from the National Institutes of Health in 2017.
As a postdoctoral fellow in the Saez Rodriguez group, you will develop and apply computational methods and tools to study cellular organisation, gene regulation and intra- and intercellular cell-cell communication to extract disease mechanisms from single-cell and spatially resolved multi-omic data.
Synthetic Chemist
Research Scientist 2/Senior Research Scientist depending on experience
Role Summary
In-vivo Biologist, Oncology
Research Scientist 2/Senior Research Scientist depending on experience
Role Summary
Cell Biologist, Oncology
Research Scientist 2/Senior Research Scientist depending on experience
Role Summary
Pioneer Group, a leader in life science infrastructure and venture-building, has appointed industry leader, Chris Walters, as Portfolio Director and European Acquisitions Lead.
Chris brings extensive experience in life sciences real estate, supported by a strong network of relationships across academia, research institutes, public sector bodies and real estate capital. His appointment will play a pivotal role in advancing Pioneer’s growth strategy and strengthening its position as a global leader in science-focused commercial real estate.
Nominations are now officially open for the inaugural Private Business Awards
Sponsored by BDO, the awards serve to celebrate the UK’s mid-sized businesses that are driving UK economic growth
The Private Business Awards 2025, sponsored by BDO, has officially launched, with nominations now open to all UK registered private or PE-backed businesses with a turnover of £50m-£300m.